Healthdirect Australia is not responsible for the content and advertising on the external website you are now entering.
Active ingredients: cabergoline
What it is used for
INDICATIONS AS AT 10 JUNE 2004 : Inhibition of physiological lactation - Dostinex is indicated for the prevention of the onset of physiological lactation in the puerperium for clearly defined medical reasons. Treatment of hyperprolactinemic disorders - Dostinex is indicated for the treatment of pathological hyperprolactinaemia.
How to take it
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
- The way to take this medicine: Oral
- Store below 25 degrees Celsius
- Lifetime is 24 Months.
Always read the label. If symptoms persist see your healthcare professional.
Flat capsule shaped 4 x 8mm white tablets. On one surface-the letter 'P' on a side of the score and the letter 'U' on the other. On other surface-the number '700' with a short score in the middle of the upper and lower extremity of the tablet surface
Images are the copyright of the Pharmacy Guild of Australia
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Is this medicine subsidised?
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on 1 October 2018. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
Pregnant or planning a pregnancy?
For the active ingredient cabergoline
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
For side effects, taking other medicines and more
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems